In memoriam: Sten Orrenius
Sten Orrenius, a toxicologist known for groundbreaking research on drug metabolism and an honorary member of the American Society for Biochemistry and Molecular Biology since 1986 died in April 2020, the ASBMB learned recently. He was 83.

Born February 14, 1937, Orrenius spent his early childhood on a farm in southern Sweden. He originally planned to study law, but after a serious car accident kept him hospitalized for many months, he applied for medical school instead. While a student at the Karolinska Institute in Stockholm, he worked in the pathology lab. He ended up earning both a medical degree and a Ph.D. studying the function of drug-metabolizing enzymes in the liver in Lars Ernster’s lab at the the Wenner–Gren Institute, then did a postdoc at Yale University and the University of Texas Southwestern Medical School at Dallas, continuing his noted work on the carbon monoxide–binding pigment cytochrome P450.
Orrenius returned to the Karolinska Institute in 1971 as a professor of forensic medicine, and in 1984 he moved to the toxicology department. For many years he was one of the most cited researchers at the institute, where he remained throughout his career; he also served as dean of the Faculty of Medicine and founded and chaired the Institute of Environmental Medicine.
In his lab, Orrenius used freshly isolated hepatocytes, at the time a novel system, to investigate cytotoxicity and cell death, focusing on the role of calcium. His group showed that mitochondrial calcium buffering is key to preventing oxidative cell damage and that excess calcium mediates DNA fragmentation during apoptosis; they also found out how mitochondria become permeable to calcium early in the cell death process. He determine that cytochrome C, too, is released from mitochondria and can induce death when microinjected into cells.
Eventually, Orrenius became interested in crosstalk between different modes of cell death. He studied one set of neurons in the cerebellum that, during periods of low oxygen such as a stroke, can die by either rapid necrosis or delayed apoptosis depending on how their mitochondria function. In one of his last papers, he underlined the importance of untangling the many pathways to cell death for the future of toxicology.
Orrenius served on both the Nobel Assembly and the Nobel Committee at the Karolinska Institute for many years and was a member of the Swedish Royal Academy of Sciences and a foreign associate member of the Academy of Medicine of the U.S. National Academy of Sciences.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Meet Lan Huang
Molecular & Cellular Proteomics associate editor uses crosslinking mass spec to study protein–protein interactions to find novel therapeutics.

Meet Shannon Reilly
The JLR junior associate editor discusses the role of adipocytes in obesity at Weill Cornell Medical School.

Meet Donita Brady
Donita Brady is an associate professor of cancer biology and an associate editor of the Journal of Biological Chemistry, who studies metalloallostery in cancer.

Glyco get-together exploring health and disease
Meet the co-chairs of the 2025 ASBMB meeting on O-GlcNAcylation to be held July 10–13, 2025, in Durham, North Carolina. Learn about the latest in the field and meet families affected by diseases associated with this pathway.

ASBMB recognizes 2025 outstanding student chapter
The Purdue group, led by Orla Hart, developed STEM outreach initiatives for low-income and minority students in Lafayette, Indiana.

ASBMB inducts 2025 honor society members
Chi Omega Lambda, which recognizes exceptional juniors and seniors pursuing degrees in the molecular life sciences, has 16 new inductees in 2025.